BioSpace News Archive

Deals

/R E P E A T -- Canopy Growth to Announce Fourth Quarter and Fiscal Year 2019 Financial Results/

Canopy Growth Corporation will release its financial results for the fourth quarter and fiscal year ended March 31, 2019 after financial markets close on June 20, 2019.

June 10, 2019
·
4 min read
Business

NanoViricides, Inc. Appoints Dr. Mark Day to its Board of Directors

NanoViricides, Inc., a leader in developing novel nanomedicines to treat viral diseases, reports that Dr. Mark Day has been duly appointed as an Independent Director to its Board of Directors, effective June 6, 2019.

June 10, 2019
·
5 min read
Deals

OTC Markets Group Welcomes NervGen Pharma to OTCQX

OTC Markets Group Inc. announced NervGen Pharma Corp., a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, has qualified to trade on the OTCQX® Best Market.

June 10, 2019
·
2 min read
Genetown

Tetraphase Pharmaceuticals Announces New XERAVA™ (eravacycline) Data at the 39th Annual Surgical Infection Society Meeting

Study Examines Microbiology and Hospitalization Outcomes Among Complicated Intra-Abdominal Infection Patients

June 10, 2019
·
11 min read
Job Trends

MX3 Diagnostics Emerges from Stealth, Announces World’s First Portable, Reliable Saliva-Based Hydration Testing System

MX3 Diagnostics Inc., a startup that has developed the world’s first real-time saliva-based hydration test, announced the pre-order availability of its flagship portable product, the MX3 Hydration Testing System Pro Version.

June 10, 2019
·
4 min read
Business

Acceleron Announces Retirement of Director and Co-Founder Tom Maniatis

Acceleron Pharma Inc. announced that company co-founder Tom Maniatis, PhD, is retiring from his position on its Board of Directors and will continue to serve the organization in an advisory capacity as Director Emeritus.

June 10, 2019
·
3 min read
Deals

Flex Pharma Announces that ISS and Glass Lewis Recommend Shareholders Vote “FOR” All Agenda Items relating to Flex’s Strategic Merger with Salarius Pharmaceuticals

Flex Pharma, Inc. announced that Institutional Shareholder Services Inc. and Glass Lewis recommend that shareholders vote FOR all agenda items before or at Flex Pharma’s June 14 Special Shareholders Meeting.

June 10, 2019
·
7 min read
Deals

TherapeuticsMD to Host Investor and Analyst Day Today

TherapeuticsMD, Inc., an innovative, leading women’s healthcare company, will host its Investor and Analyst Day in New York City.

June 10, 2019
·
4 min read
Genetown

ArQule Announces Oral Presentation for its Pan-AKT Inhibitor, Miransertib, at the 2019 European Society of Human Genetics (ESHG) Conference

Presentation highlights preliminary results from phase 1/2 study of miransertib in patients with PIK3CA-related Overgrowth Spectrum (PROS) and Proteus Syndrome (PS)

June 10, 2019
·
3 min read
Drug Development

Deciphera Pharmaceuticals, Inc. Expands Pipeline with Potential First-in-Class Autophagy Inhibitor to Treat Mutant RAS Cancers

Company to Host a Webcast on Tuesday, June 18, 2019 at 8 a.m. ET to Discuss Autophagy Inhibition and the Treatment of Mutant RAS Cancers

June 10, 2019
·
8 min read